Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

British journal of haematology - 1 Sept 2016

Erickson Stephen W, Stephens Owen W, Chavan Shweta S, Epstein Joshua, Barlogie Bart, Heuck Christoph J, Vangsted Annette J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Variation
Share to Intracellular Signaling Peptides and Proteins
Share to Multiple Myeloma

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prognosis

Share to RNA Polymerase I

Share to Survival Analysis

Share to Treatment Outcome

Source

Identifiers

PMID: 26568154
DOI: 10.1111/bjh.13830

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.PMID 26568154Read ↗

Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma.Semantic proximity Read ↗

Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patientsSemantic proximity Read ↗

Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry studySemantic proximity Read ↗

Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.Semantic proximity Read ↗

Impact of genetic abnormalities after allogeneic stem cell transplantation in multiple myeloma: a report of the Societe Francaise de Greffe de Moelle et de Therapie CellulaireSemantic proximity Read ↗

Genetic mutations and outcome in myeloma.Semantic proximity Read ↗

CYP2C19*2 gene variant (G681A, rs4244285) as a prognostic marker for the clinical course of multiple myeloma.Semantic proximity Read ↗

A novel mutation involving the carboxy terminal region of the FGFR3 gene in a multiple myeloma patient with t(4;14).Semantic proximity Read ↗

p53 haploinsufficiency and functional abnormalities in multiple myeloma.Semantic proximity Read ↗

<i>TP53</i> deletion is not an adverse feature in multiple myeloma treated with total therapy 3Semantic proximity Read ↗

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high‐dose chemotherapy in patients with multiple myelomaSemantic proximity Read ↗

Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.